Abstract
A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer's disease dementia should provide insights into whether anti-amyloid therapy can delay cognitive decline.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have